MR elastography is highly repeatable and weakly correlates with age.
MR elastography-derived shear stiffness can be an objective biomarker of the intervertebral disc (IVD) degeneration process, according to a recent study. In a cross-sectional study, published in Radiology, in vivo lumbar MR elastography was performed once in the morning and once in the afternoon in 47 subjects without low back pain. Patients were ages 20 to 71 years. Researchers used principal frequency analysis to assess degeneration grade and MR elastography-derived sheer stiffness of the nucleus pulposus and annulus fibrous regions of all lumbar IVDs. According to results, there were no significant differences between morning and afternoon shear stiffness at all levels, and technical repeating between morning and afternoon imaging results for both nucleus pulposus (R=0.92) and annulus fibrous (R=0.83) regions were very good. Both experienced significant increases in MR elastography shear stiffness with increasing degeneration grade (nucleus pulposus grade 1, 12.5 kPa ± 1.3; grade 5, 16.5 kPa ± 2.1; annulus fibrosus grade 1, 90.4 kPa ± 9.3; grade 5, 120.1 kPa ± 15.4). There were weak correlations between shear stiffness and age at all levels. Overall, researchers wrote, MR elastography-derived shear stiffness measures were highly repeatable, correlated weakly with age, and increase with advancing IVD degeneration. This could suggest the stiffness may provide an objective biomarker of IVD degeneration processes.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.